Direxion Daily Healthcare Bull 3X Shares
CURE
NYSE Arca
| Weiss Ratings | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Valuation | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $153.53 | |||
| Company Info | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Direxion Funds | |||
| Manager/Tenure (Years) | Paul Brigandi (15), Tony Ng (11) | |||
| Website | http://www.direxionfunds.com | |||
| Phone Number | 646-572-3390 | |||
| Fund Information | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Direxion Daily Healthcare Bull 3X Shares | |||
| Category | Trading--Leveraged Equity | |||
| Sub-Category | Trading Tools | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 15, 2011 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.98% | |||
| Dividend | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.64% | |||
| Asset Allocation | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 4.37% | |||
| Stock | 21.21% | |||
| U.S. Stock | 21.21% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 74.42% | |||
| Price History | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.92% | |||
| 30-Day Total Return | 17.73% | |||
| 60-Day Total Return | 6.07% | |||
| 90-Day Total Return | 29.23% | |||
| Year to Date Total Return | 38.84% | |||
| 1-Year Total Return | 62.84% | |||
| 2-Year Total Return | 30.67% | |||
| 3-Year Total Return | 86.63% | |||
| 5-Year Total Return | 37.41% | |||
| Price | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $153.59 | |||
| 1-Month Low Price | $124.02 | |||
| 1-Month High Price | $159.07 | |||
| 52-Week Low Price | $83.61 | |||
| 52-Week Low Price (Date) | May 11, 2026 | |||
| 52-Week High Price | $159.07 | |||
| 52-Week High Price (Date) | Oct 22, 2026 | |||
| NAV | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $123.65 | |||
| 1-Month High NAV | $158.87 | |||
| 52-Week Low NAV | $83.68 | |||
| 52-Week Low NAV (Date) | May 11, 2026 | |||
| 52-Week High NAV | $158.87 | |||
| 52-Week High Price (Date) | Oct 22, 2026 | |||
| Beta / Standard Deviation | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.24 | |||
| Standard Deviation | 42.54 | |||
| Balance Sheet | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 167.54M | |||
| Operating Ratios | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.94% | |||
| Turnover Ratio | 1.00% | |||
| Performance | CURE - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 32.55% | |||
| Last Bear Market Total Return | -20.67% | |||